Ekso Bionics Holdings designs, develops, and markets exoskeleton products. Co.'s products for rehabilitation applications include: EksoNR, which is a wearable bionic exoskeleton that allows hospitals and other rehabilitation providers to deliver over ground gait therapy and ambulation assistance; Ekso Indego Therapy, which can be custom-sized and provided to patients allowing for swift donning; and Ekso Indego Personal, which enables people with mobility impairments the opportunity to walk independently. Co.'s primary product for able-bodied industrial applications is EVO, which elevates and supports a worker's arms to assist them with tasks ranging from chest height to overhead. The EKSO stock yearly return is shown above.
The yearly return on the EKSO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the EKSO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|